In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y. Journal Articles

abstract

• Perkovic V, Tuttle KR, Rossing P, et al; FLOW Trial Committees and Investigators. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med. 2024;391:109-121. 38785209.

authors

• Collister, David
• Pannu, Neesh

status

• published 

publication date

• September 2024

has subject area

• 1103 Clinical Sciences (FoR)
• 1117 Public Health and Health Services (FoR)

published in

• ACP journal club  Journal

keywords

• 3 Good Health and Well Being
• 32 Biomedical and Clinical Sciences
• 3202 Clinical Sciences
• Clinical Research
• Clinical Trials and Supportive Activities
• Diabetes
• Kidney Disease
• Renal and urogenital

Digital Object Identifier (DOI)

• 10.7326/ANNALS-24-01579-JC

PubMed ID

• 39222509

start page

• JC98

volume

• 177

issue

• 9